Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Earnings estimates for Ellie Mae, Inc. ( ELLI - Snapshot Report ) are rising after this provider of mortgage automation software announcing impressive second quarter results, including a positive surprise of more than 90% and a raised fiscal 2012 guidance. All estimates for this year have moved higher in the past week, underscoring the companys Zacks #1 Rank (Strong Buy).
Currently, the stock is trading around its 52-week high. There is also a potential for further upside based on Ellie Maes solid growth projection for fiscal 2012 and the Feds decision to make open-market purchases of mortgage securities.
Stellar Q2
On August 1, 2012, Ellie Mae reported fiscal second quarter 2012 earnings per share (EPS) of 23 cents, beating the Zacks Consensus Estimate by a massive 91.67%. Net sales jumped 106.0% over the comparable prior-year quarter to $23.6 million, topping the Zacks Consensus Estimate of $20.0 million.
The revenue improvement was mostly driven by rapid adoption of its on-demand SaaS Encompass solutions by mortgage firms. On-demand revenue surged 112.0% year over year. Revenues from on-premise solutions (which include software products and license fees) surged 72.0% year over year.
Gross margin improved 820 bps from the year-ago quarter to 77.6%. Despite a 62.3% year-over-year increase in operating expenses, operating margin increased significantly to 22.3% from (0.6%) in the year-ago quarter. The rise in expenses was more than offset by a higher level of cost absorption.
Guidance Upbeat
For the third quarter, Ellie Mae expects revenue between $23.75 million and $24.25 million. Projected non-GAAP net income is expected between $5.0 million and $5.4 million, while non-GAAP EPS is seen at 18 cents to 20 cents. Expectations for sustained business momentum and a favorable mortgage environment led the company to raise its fiscal 2012 guidance. Ellie Mae now expects fiscal 2012 revenue of $90 million to $91 million, up from the previous range of $78.0 million $79.0 million. Non-GAAP net income is expected between $17.1 million and $18.0 million, up from $9.6 million to $10.1 million. Non-GAAP EPS is seen between 68 cents and 72 cents (previously 42 cents 45 cents).
Zacks Consensus Estimates Jump
All 8 estimates for the third quarter have advanced in the past 7 days.. The Zacks Consensus Estimate for the quarter has surged 233.3% to 20 cents.
The full-year 2012 estimate also went up unanimously in the past week as all 8 estimates increased, lifting the Zacks Consensus Estimate by 66% to 73 cents. Meanwhile, the Zacks Consensus Estimate for 2013 is up more than 25% to 74 cents.
Valuation Looks Attractive
Ellie Mae shares are up 337.61% year to date compared with a 9.2% increase for the S&P 500.
Shares are trading at a premium to its peers. It has a forward P/S of 6.72 and a P/B of 6.02, against 1.95 and 1.56, respectively, for its peers. The PEG of 1.5 is also higher than the 0.7 for the industry. However, considering the fact that Ellie Mae has a 1-year return on equity of 16.8%, which is well above the 4.5% of its peers; there appears to be further upside to the shares.
6-Month Chart
Ellie Mae competes with tech behemoths such as Microsoft Corp. (MSFT), Oracle Corp. (ORCL) and Fiserv Inc. (FISV) in the mortgage-solutions arena. However, its shares have traded at a premium to its rivals.
The significant increase in the stock price in recent months was on account of encouraging sales trends and market share gains. The stock is currently above its 50 and 200-day moving averages of 18.94 and 13.15, respectively.
Trading volumes are considerably lower than its peers.
Founded in 1997, California-based Ellie Mae is a provider of end-to-end business automation solutions for residential mortgage purposes. Mid-sized mortgage banks, mortgage brokers, and credit unions cater to Ellies flagship solutions to expedite mortgage processing. The solution facilitates error-free and regulatory compliant documentation, which speeds up origination and funding of new mortgages.
Read the full Snapshot Report on ELLI